Womens Health

Benign Fibrous Tumors of the Pleura – types, causes, symptoms, diagnosis, prevention, treatments, and Home Remedies

womens-health-magazine-default-image

Written by

divi

in

,

Benign Fibrous Tumours of the Pleura: Symptoms, Diagnosis and Treatment

Table of Contents

Key takeaways

  • Benign fibrous tumours of the pleura are uncommon growths that usually arise from the pleural lining around the lung.
  • Many are now described as solitary fibrous tumours because similar tumours can occur in other body sites.
  • Some cause no symptoms and are found on imaging; larger tumours may cause breathlessness, chest discomfort or cough.
  • Assessment usually needs chest imaging and specialist review, and treatment is commonly surgical removal when appropriate.
  • New chest pain, coughing blood, severe breathlessness or unexplained weight loss should be assessed promptly.

Overview

A benign fibrous tumour of the pleura is a rare tumour that develops from the pleura, the thin membrane that lines the chest wall and covers the lungs. In modern medical writing, these tumours are often grouped under the term solitary fibrous tumour. They are usually slow-growing and may be non-cancerous, but specialist assessment is still important because some solitary fibrous tumours can behave aggressively or recur after treatment.

The pleura has two layers. The visceral pleura covers the lung surface, while the parietal pleura lines the inside of the chest wall. A fibrous pleural tumour grows from connective-tissue-type cells rather than from lung airways. This distinction matters because it is not the same condition as lung cancer, mesothelioma, pneumonia or pleural effusion, although symptoms and imaging findings can overlap.

Older articles sometimes use broad phrases such as benign fibrous tumour of the pleura, localised fibrous tumour, or fibrous mesothelioma. Current classification usually avoids calling these tumours mesothelioma because their biology, cell markers and treatment pathway are different. The most useful reader question is therefore not only whether the mass is benign, but whether it has been fully characterised and whether long-term follow-up is needed.

Symptoms

Small pleural fibrous tumours may cause no symptoms. They are often found incidentally when a chest X-ray, CT scan or other imaging test is performed for another reason. When symptoms occur, they are usually related to the size and position of the tumour and whether it presses on the lung, chest wall or nearby structures.

Possible symptoms include:

  • Shortness of breath, especially on exertion.
  • Chest discomfort, heaviness or pain.
  • A persistent cough.
  • A feeling of pressure in the chest.
  • Recurrent chest infections or reduced exercise tolerance in some cases.
  • Unexplained fatigue or weight loss, which needs careful assessment because it is not specific.

A small number of solitary fibrous tumours are associated with low blood sugar due to tumour production of insulin-like growth factor, a rare paraneoplastic effect sometimes called Doege-Potter syndrome. Symptoms can include sweating, shakiness, confusion or faintness. This is uncommon, but it illustrates why specialist review is needed rather than relying on symptoms alone.

Causes and risk factors

The exact cause is not usually known. Solitary fibrous tumours are characterised by abnormal growth of mesenchymal cells, the type of tissue that can form connective and supportive structures. Many have a specific NAB2-STAT6 gene fusion within tumour cells. This is an acquired tumour-cell change, not usually an inherited family trait. Pathologists can use STAT6 staining and other markers to help confirm the diagnosis on tissue samples.

Unlike mesothelioma, solitary fibrous tumour of the pleura is not classically defined as an asbestos-driven disease. Age at diagnosis is often adulthood, and there is no simple prevention strategy. Risk assessment focuses on tumour size, location, growth pattern, cellular features under the microscope, mitotic activity, necrosis and whether complete removal is possible.

The word benign should be used carefully. Some tumours that look low risk can recur, and some have malignant features. This is why follow-up plans may continue after surgery even when the initial operation is successful.

Diagnosis

Diagnosis usually starts with imaging. A chest X-ray may show a mass, but CT scanning gives more detail about size, attachment to the pleura, relationship to the lung and whether there are features that raise concern. MRI or PET-CT may be used in selected cases when specialists need more information for surgical planning or risk assessment.

A tissue diagnosis may be needed, often through image-guided biopsy or surgical sampling. The pathologist examines the cell pattern and may use immunohistochemistry, including STAT6, CD34 and other markers, to distinguish solitary fibrous tumour from mesothelioma, sarcoma, metastatic disease or other pleural conditions. Biopsy decisions are individual because tumour position, bleeding risk and the likelihood of proceeding to surgery all matter.

Assessment is usually led by a respiratory physician, thoracic surgeon, radiologist and pathologist, often through a multidisciplinary team. This is particularly important when symptoms are significant, the mass is large, or imaging suggests possible malignant behaviour.

Treatment and follow-up

When suitable, complete surgical removal is the main treatment for a resectable pleural solitary fibrous tumour. Surgery may be performed with video-assisted thoracoscopic surgery or an open approach, depending on tumour size, attachment and complexity. The aim is to remove the tumour fully while preserving lung function where possible.

Non-surgical management may be considered when a person is not fit for surgery, the tumour is very small and low risk, or specialist assessment suggests monitoring is reasonable. Radiotherapy, systemic treatment or further specialist oncology input may be discussed when a tumour has malignant features, cannot be fully removed or recurs. These decisions are highly individual and should be explained by the treating team.

Follow-up usually involves scheduled imaging. The interval and duration depend on the tumour’s risk features and the completeness of removal. Because late recurrence can occur, people should keep follow-up appointments even after feeling well.

Living with monitoring

Self-care cannot shrink a pleural fibrous tumour, but it can support safety while waiting for assessment or follow-up. Keep a record of breathlessness, chest pain, cough, weight changes and exercise tolerance. Bring previous imaging reports and operation notes to appointments if care has moved between hospitals.

Smoking cessation, vaccination where appropriate, pulmonary rehabilitation advice and management of other lung or heart conditions may improve overall respiratory resilience, but they do not replace tumour-specific care. Avoid unverified remedies that claim to remove tumours, and check supplements with a clinician because some can affect bleeding risk before procedures.

When to seek medical advice

Arrange medical review for unexplained breathlessness, persistent cough, chest discomfort, unintentional weight loss, or any new chest imaging abnormality. Seek urgent advice through NHS 111 for worsening breathlessness, fever, coughing blood, fainting episodes, or chest pain that is not clearly explained. Call 999 for severe breathing difficulty, crushing chest pain, blue lips, collapse or symptoms suggesting a life-threatening emergency.

Sources

Disclaimer

Educational only. Results vary. Not a cure.

SEO metadata

SEO title: Benign Fibrous Tumours of the Pleura Explained

Meta description: Learn about benign fibrous tumours of the pleura, symptoms, causes, diagnosis, surgery, monitoring and when chest symptoms need medical advice.

Suggested slug: benign-fibrous-tumours-of-the-pleura

Article type: medical_condition

Details to confirm before publishing: Confirm whether the site style guide prefers tumour or tumor in article slugs; body copy uses British English.

More posts